Robert C. Rose

Medicine · Health Sciences

36h-index4.6kcitations65works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cervical Cancer and HPV Research(34), Virus-based gene therapy research(21), Immunotherapy and Immune Responses(11), Hepatitis B Virus Studies(9), Animal Virus Infections Studies(9)

Publications65 total

Diagnosis
2019
Developing a Tagged CRISPR‐Cas9 Enhancer Pull‐Down Assay
The FASEB Journal·2017
Utilizing the CRISPR‐Cas System to Excise and Study the Insulin Enhancer
The FASEB Journal·2016
Lymphatic and cancer tissues are a potential reservoir of replicating virus in virally suppressed ART + patients
Journal of Virus Eradication·2015· 1 citedOpen Access
Difference between the Abilities of Human Fcγ Receptor-Expressing CV-1 Cells To Neutralize American and Asian Genotypes of Dengue Virus 2
Clinical and Vaccine Immunology·2013Open Access
A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
Vaccine·2010· 63 cited
Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN)
International Journal of Infectious Diseases·2010· 40 citedOpen Access
Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection
Vaccine·2009· 22 citedOpen Access
Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype
Virology·2009· 54 citedOpen Access
Tracking serum antibody response to viral antigens with arrayed imaging reflectometry
Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE·2009· 5 cited
Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres
Virology Journal·2009· 25 citedOpen Access
An Automated Dengue Virus Microneutralization Plaque Assay Performed in Human Fcγ Receptor-expressing CV-1 Cells
American Journal of Tropical Medicine and Hygiene·2009· 43 cited
Difference between the Abilities of Human Fcγ Receptor-Expressing CV-1 Cells To Neutralize American and Asian Genotypes of Dengue Virus 2
Clinical and Vaccine Immunology·2008· 17 citedOpen Access
Dengue vaccine development and dengue viral neutralization and enhancement assays
Antiviral Therapy·2008· 21 citedOpen Access
Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells
Journal of Medical Virology·2007· 207 cited
Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In Vitro
Journal of Virology·2007· 130 citedOpen Access
Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo
Vaccine·2007· 43 cited
Cyclooxygenase-2 Inhibition Attenuates Antibody Responses against Human Papillomavirus-Like Particles
The Journal of Immunology·2006· 36 citedOpen Access
Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human FcγRIA (CD64) or FcγRIIA (CD32)
Journal of Virology·2006· 119 citedOpen Access
Prevalence of Human Papillomavirus Genotypes and Related Abnormalities of Cervical Cytological Results among HIV‐1–Infected Women in Rochester, New York
The Journal of Infectious Diseases·2006· 68 cited
page 1 of 4Next →

Frequent Co-authors

William Bonnez(13), Richard C. Reichman(12), Anna‐Lise Williamson(11), Christopher Lane(10), Jacob J. Schlesinger(7), Xia Jin(7), Dianne J. Marais(7), Junona Moroianu(5), W. W. Shanaka I. Rodrigo(4), Edward P. Rybicki(4), Patti Kay(4), Robert L. Garcea(3), Matthew Quinn(3), Wendy I. White(3), JoAnn Suzich(3), Carrie Da Rin(3), Lisa M. Nelson(3), John G. Frelinger(2), Edith M. Lord(2), Zhihua Kou(2)